William J. Robb, III, M.D. has been appointed orthopedic director, chief medical officer of Illinois Bone & Joint Institute (IBJI). Dr. Robb joined IBJI in 1995 and has 40 years of surgical experience, specializing in adult knee disorders.
William J. Robb, III, M.D.: New Orthopedic Director, CMO at IBJI

“Dr. Robb is one of America’s leading orthopedic surgeons and has been repeatedly recognized for his leadership qualities and contributions to the orthopedics field. Since joining IBJI he has played an integral role in directing the mission, focus and growth of our practice,” said Andre Blom, IBJI chief operating officer. “In his new role as orthopedic director, chief medical officer, Dr. Robb will take the lead in overseeing clinical operations as IBJI continues to deliver optimal outcomes for our patients.”
According to IBJI, “Dr. Robb, a graduate of University of Iowa Medical School, completed his internship and initial residency in general surgery at Duke University Medical Center in North Carolina, then returned to Iowa to complete the orthopaedic surgery residency at University of Iowa Hospitals and Clinics.”
“He has published numerous pieces of scholarly research and his contributions to the field have been lauded with a number of industry awards, including the 2017 W.W. Tipton Leadership Award from the American Academy of Orthopaedic Surgeons.”
“He has held leadership positions at the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons and Illinois Orthopaedic Society; and from 2005-2012, he served as Chairman of the NorthShore University Health System’s Department of Orthopaedic Surgery.”
Dr. Robb told OTW, “Five years ago IBJI began evaluating the opportunity to participate in the Bundled Payment Care Initiative (BPCI) program with CMS [Centers for Medicare and Medicaid Services]—an innovative payment program for IBJI’s total hip and knee replacement patients based upon the redesign of rehabilitation care following hospital discharge.”
“As the medical director of this very successful IBJI program, IBJI is now positioned to expand these efforts through similar care redesign which can improve the quality of outcomes for many of our patients.”
“Based upon our experience and successes with the BPCI program designed primarily for hip and knee replacement patients, new centers of excellence will be developed for other common orthopedic and musculoskeletal diseases including spine care, shoulder care and sports care. I look forward to working closely with all IBJI surgeons and administrative leaders to improve care for our many patients across the Chicago area.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.